CAREDX, INC. Deferred Revenue
CAREDX, INC. (CDNA) had Deferred Revenue of $3.62 million as of 2019-06-30, per its 10-Q filed 2019-08-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-08-01
- 2019-06-30: Deferred Revenue, Current $3.62M.
- 2019-03-31: Deferred Revenue, Current $47.00K.
- 2018-12-31: Deferred Revenue, Current $39.00K.
- 2018-09-30: Deferred Revenue, Current $39.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2019-06-30 | $3.62M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $47.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $39.00K 10-Q · filed 2019-08-01 |
| 2018-09-30 | $39.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $39.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $39.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $39.00K 10-K · filed 2019-03-06 |
| 2017-09-30 | $39.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $39.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $39.00K 10-Q · filed 2017-06-09 |
| 2016-12-31 | $42.00K 10-K · filed 2018-03-22 |
| 2016-09-30 | $58.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $65.00K 10-Q · filed 2016-08-22 |
| 2016-03-31 | $137.00K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $142.00K 10-K · filed 2017-04-21 |
| 2015-09-30 | $136.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $500.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $488.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $505.00K 10-K · filed 2016-03-29 |
| 2014-09-30 | $673.00K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $674.00K 10-Q · filed 2014-08-28 |
| 2013-12-31 | $80.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |